HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ROS-Triggered Self-Assembled Nanoparticles Based on a Chemo-Sonodynamic Combinational Therapy Strategy for the Noninvasive Elimination of Hypoxic Tumors.

Abstract
The hypopermeability and hypoxia in the tumor milieu are important factors that limit multiple treatments. Herein, the reactive oxygen species (ROS)-triggered self-assembled nanoparticles (RP-NPs) was constructed. The natural small molecule Rhein (Rh) was encapsulated into RP-NPs as a sonosensitizer highly accumulated at the tumor site. Then highly tissue-permeable ultrasound (US) irradiation induced apoptosis of tumor cells through the excitation of Rh and acoustic cavitation, which prompted the rapid production of large amounts of ROS in the hypoxic tumor microenvironment. In addition, the thioketal bond structures in the innovatively designed prodrug LA-GEM were triggered and broken by ROS to achieve rapid targeted release of the gemcitabine (GEM). Sonodynamic therapy (SDT) increased the tissue permeability of solid tumors and actively disrupted redox homeostasis via mitochondrial pathways to kill hypoxic tumor cells, and the triggered response mechanism to GEM synergistically amplified the effect of chemotherapy. The chemo-sonodynamic combinational treatment approach is highly effective and noninvasive, with promising applications for hypoxic tumor elimination, such as in cervical cancer (CCa) patients who want to maintain their reproductive function.
AuthorsYibing Li, Ling Lin, Jiashan Xie, Lixue Wei, Shuping Xiong, Kunyi Yu, Bingchen Zhang, Shengtao Wang, Zibo Li, Yan Tang, Guimei Chen, Zhongjun Li, Zhiqiang Yu, Xuefeng Wang
JournalACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 15 Issue 12 Pg. 15893-15906 (Mar 29 2023) ISSN: 1944-8252 [Electronic] United States
PMID36940438 (Publication Type: Journal Article)
Chemical References
  • Reactive Oxygen Species
  • Gemcitabine
Topics
  • Reactive Oxygen Species (chemistry)
  • Nanoparticles (chemistry)
  • Neoplasms (drug therapy, pathology)
  • Intracellular Space
  • Tumor Microenvironment
  • Tumor Hypoxia
  • Drug Delivery Systems
  • Gemcitabine (chemistry, pharmacology)
  • Combined Modality Therapy
  • Humans
  • Animals
  • Mice
  • HeLa Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: